Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats

Ko Omura, Takeki Uehara, Yuji Morikawa, Hitomi Hayashi, Kunitoshi Mitsumori, Keiichi Minami, Masayuki Kanki, Hiroshi Yamada, Atsushi Ono, Tetsuro Urushidani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.

Original languageEnglish
Pages (from-to)785-794
Number of pages10
JournalJournal of Toxicological Sciences
Volume39
Issue number5
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Thioacetamide
Methapyrilene
Carcinogens
Rats
Acetaminophen
Phenobarbital
Liver
DNA Damage
Genes
Toxicogenetics
Diethylnitrosamine
DNA
Glutathione Transferase
Transcriptome
Gene expression
Cluster Analysis
Tumors
Gene Expression
Growth
Neoplasms

Keywords

  • Altered hepatocellular foci
  • GST-P carcinogenesis
  • Liver

ASJC Scopus subject areas

  • Toxicology
  • Medicine(all)

Cite this

Omura, K., Uehara, T., Morikawa, Y., Hayashi, H., Mitsumori, K., Minami, K., ... Urushidani, T. (2014). Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats. Journal of Toxicological Sciences, 39(5), 785-794. https://doi.org/10.2131/jts.39.785

Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats. / Omura, Ko; Uehara, Takeki; Morikawa, Yuji; Hayashi, Hitomi; Mitsumori, Kunitoshi; Minami, Keiichi; Kanki, Masayuki; Yamada, Hiroshi; Ono, Atsushi; Urushidani, Tetsuro.

In: Journal of Toxicological Sciences, Vol. 39, No. 5, 2014, p. 785-794.

Research output: Contribution to journalArticle

Omura, K, Uehara, T, Morikawa, Y, Hayashi, H, Mitsumori, K, Minami, K, Kanki, M, Yamada, H, Ono, A & Urushidani, T 2014, 'Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats', Journal of Toxicological Sciences, vol. 39, no. 5, pp. 785-794. https://doi.org/10.2131/jts.39.785
Omura, Ko ; Uehara, Takeki ; Morikawa, Yuji ; Hayashi, Hitomi ; Mitsumori, Kunitoshi ; Minami, Keiichi ; Kanki, Masayuki ; Yamada, Hiroshi ; Ono, Atsushi ; Urushidani, Tetsuro. / Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats. In: Journal of Toxicological Sciences. 2014 ; Vol. 39, No. 5. pp. 785-794.
@article{a4ed2e89c343470ab49c74cad354b1db,
title = "Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats",
abstract = "We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.",
keywords = "Altered hepatocellular foci, GST-P carcinogenesis, Liver",
author = "Ko Omura and Takeki Uehara and Yuji Morikawa and Hitomi Hayashi and Kunitoshi Mitsumori and Keiichi Minami and Masayuki Kanki and Hiroshi Yamada and Atsushi Ono and Tetsuro Urushidani",
year = "2014",
doi = "10.2131/jts.39.785",
language = "English",
volume = "39",
pages = "785--794",
journal = "Journal of Toxicological Sciences",
issn = "0388-1350",
publisher = "Japanese Society of Toxicological Sciences",
number = "5",

}

TY - JOUR

T1 - Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats

AU - Omura, Ko

AU - Uehara, Takeki

AU - Morikawa, Yuji

AU - Hayashi, Hitomi

AU - Mitsumori, Kunitoshi

AU - Minami, Keiichi

AU - Kanki, Masayuki

AU - Yamada, Hiroshi

AU - Ono, Atsushi

AU - Urushidani, Tetsuro

PY - 2014

Y1 - 2014

N2 - We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.

AB - We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.

KW - Altered hepatocellular foci

KW - GST-P carcinogenesis

KW - Liver

UR - http://www.scopus.com/inward/record.url?scp=84907569588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907569588&partnerID=8YFLogxK

U2 - 10.2131/jts.39.785

DO - 10.2131/jts.39.785

M3 - Article

C2 - 25242409

AN - SCOPUS:84907569588

VL - 39

SP - 785

EP - 794

JO - Journal of Toxicological Sciences

JF - Journal of Toxicological Sciences

SN - 0388-1350

IS - 5

ER -